GAA
Green Alpha Advisors’s Editas Medicine EDIT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $376K | Sell |
170,782
-13,121
| -7% | -$28.9K | 0.36% | 77 |
|
|
2025
Q1 | $213K | Buy |
183,903
+72,275
| +65% | +$83.8K | 0.23% | 94 |
|
|
2024
Q4 | $142K | Buy |
111,628
+68,295
| +158% | +$86.7K | 0.11% | 137 |
|
|
2024
Q3 | $148K | Buy |
43,333
+13,066
| +43% | +$44.6K | 0.12% | 128 |
|
|
2024
Q2 | $141K | Sell |
30,267
-15,818
| -34% | -$73.9K | 0.11% | 125 |
|
|
2024
Q1 | $342K | Buy |
46,085
+163
| +0.4% | +$1.21K | 0.25% | 117 |
|
|
2023
Q4 | $465K | Sell |
45,922
-31,266
| -41% | -$317K | 0.34% | 110 |
|
|
2023
Q3 | $602K | Buy |
77,188
+15,343
| +25% | +$120K | 0.46% | 81 |
|
|
2023
Q2 | $509K | Buy |
61,845
+3,174
| +5% | +$26.1K | 0.33% | 106 |
|
|
2023
Q1 | $425K | Sell |
58,671
-984
| -2% | -$7.13K | 0.3% | 114 |
|
|
2022
Q4 | $529K | Buy |
59,655
+2,857
| +5% | +$25.3K | 0.44% | 92 |
|
|
2022
Q3 | $695K | Sell |
56,798
-283,146
| -83% | -$3.46M | 0.59% | 77 |
|
|
2022
Q2 | $4.02M | Buy |
339,944
+291,531
| +602% | +$3.45M | 0.92% | 34 |
|
|
2022
Q1 | $921K | Buy |
48,413
+12,199
| +34% | +$232K | 0.62% | 69 |
|
|
2021
Q4 | $961K | Buy |
36,214
+4,552
| +14% | +$121K | 0.65% | 77 |
|
|
2021
Q3 | $1.3M | Buy |
31,662
+737
| +2% | +$30.3K | 0.9% | 41 |
|
|
2021
Q2 | $1.75M | Buy |
30,925
+20,372
| +193% | +$1.15M | 1.19% | 21 |
|
|
2021
Q1 | $443K | Buy |
10,553
+4,517
| +75% | +$190K | 0.44% | 85 |
|
|
2020
Q4 | $423K | Buy |
+6,036
| New | +$423K | 0.51% | 73 |
|